XOHREO Trademark

Trademark Overview

On Monday, October 22, 2018, a trademark application was filed for XOHREO with the United States Patent and Trademark Office. The USPTO has given the XOHREO trademark a serial number of 79246700. The federal status of this trademark filing is REGISTERED as of Tuesday, July 23, 2019. This trademark is owned by Nova Bio-Pharma Technologies Ltd. The XOHREO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations, namely, oral solutions for use in the treatment of sickle cell anemia; oral solutions consisting of liquid medicine for treating sickle cell anemia

Oral syringes for the delivery of liquid medication
xohreo

General Information

Serial Number79246700
Word MarkXOHREO
Filing DateMonday, October 22, 2018
Status700 - REGISTERED
Status DateTuesday, July 23, 2019
Registration Number5809489
Registration DateTuesday, July 23, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, oral solutions for use in the treatment of sickle cell anemia; oral solutions consisting of liquid medicine for treating sickle cell anemia
Goods and ServicesOral syringes for the delivery of liquid medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, December 3, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNova Bio-Pharma Technologies Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameNova Bio-Pharma Technologies Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameNova Bio-Pharma Technologies Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, November 29, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 7, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, January 29, 2019ASSIGNED TO EXAMINER
Wednesday, January 30, 2019NON-FINAL ACTION WRITTEN
Thursday, January 31, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, February 9, 2019REFUSAL PROCESSED BY MPU
Saturday, February 9, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 2, 2019REFUSAL PROCESSED BY IB
Monday, March 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 17, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, May 3, 2019NOTIFICATION PROCESSED BY IB
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 23, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 4, 2019FINAL DISPOSITION PROCESSED
Monday, November 4, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 22, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 5, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 5, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 23, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, July 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

xohreo oral anemia liquid sickle cell solutions treating syringes medication medicine